Log in to your Inderes Free account to see all free content on this page.
Lundbeck
37.48 DKK
-0.11 %
Less than 1K followers
HLUN B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lundbeck
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 50.88 | 41.76 | 33.77 | 26.05 | 32.76 | 41.32 | 43.16 |
| Shares | 993.5 | 993.5 | 993.5 | 995.7 | 995.7 | 995.7 | 992.1 |
| Market cap | 50,549.3 | 41,488.6 | 33,550.5 | 25,939.1 | 32,620.5 | 41,144.0 | 42,821.2 |
| Enterprise value | 57,115.3 | 45,594.6 | 36,739.5 | 27,970.1 | 31,761.5 | 53,173.0 | - |
| EV/S | 3.4 | 2.6 | 2.3 | 1.5 | 1.6 | 2.4 | - |
| EV/EBITDA | 11.8 | 9.5 | 9.9 | 6.0 | 6.1 | 10.3 | - |
| EV/EBIT | 15.8 | 22.9 | 18.3 | 9.8 | 9.9 | 16.3 | - |
| P/E | 19.0 | 26.2 | 25.5 | 13.5 | 14.2 | 13.0 | 13.4 |
| P/B | 3.47 | 2.44 | 1.84 | 1.25 | 1.48 | 1.65 | 1.72 |
| P/S | 3.0 | 2.3 | 2.1 | 1.4 | 1.6 | 1.9 | 1.7 |
| Dividend yield | 1.6 % | 1.2 % | 1.2 % | 2.2 % | 2.1 % | 2.3 % | 2.7 % |
| Equity ratio | 40.7 % | 47.1 % | 52.7 % | 55.5 % | 58.9 % | 43.9 % | 47.8 % |
| Gearing ratio | 74.6 % | 43.6 % | 29.1 % | 26.8 % | 18.8 % | 66.7 % | 46.8 % |
Login required
This content is only available for logged in users